Saccadous provides non-invasive eye-tracking solution for diagnosing, tracking and advancing the treatment of concussions through the capture and analysis of fixational eye-movements. Our solution simplifies and mobilizes eye-tracking while leveraging a cloud-based platform for the analysis, reporting and predictive analytics.
There are over 600 known neurological disorders and conditions that affect the human nervous system and for most of them treatment options are extremely limited. Traumatic brain injury (TBI) is a major cause of death and disability in the United States, contributing to about 30% of all injury deaths. Direct medical costs and indirect costs such as lost productivity of TBI totaled an estimated $60 billion in the United States. Current methods of diagnosing concussions and monitoring recovery are inaccurate and subjective.
The business is highly scalable. The current eye-tracking technology and software can be manufactured domestically for less than $1000....
Saccadous provides non-invasive eye-tracking solution for diagnosing, tracking and advancing the treatment of concussions through the capture and analysis of fixational eye-movements. Our solution simplifies and mobilizes eye-tracking while leveraging a cloud-based platform for the analysis, reporting and predictive analytics.
There are over 600 known neurological disorders and conditions that affect the human nervous system and for most of them treatment options are extremely limited. Traumatic brain injury (TBI) is a major cause of death and disability in the United States, contributing to about 30% of all injury deaths. Direct medical costs and indirect costs such as lost productivity of TBI totaled an estimated $60 billion in the United States. Current methods of diagnosing concussions and monitoring recovery are inaccurate and subjective.
The business is highly scalable. The current eye-tracking technology and software can be manufactured domestically for less than $1000. When packages with software, case, and stand, the retail solution can be sold for $3000-$5000. Over time, mobile phone and tablet technology will include OEM camera technology, and the technology could eventually become completely app based. Screening for TBI or neurological disease and baseline testing can scale from age 10 to age 30 for athletics, to preschool through senior citizens. Bicycle accidents and playground accidents are the 1st and 3rd leading cause of concussions in age 19 & under. As the business progresses, and our data increases, early, non-invasive Alzheimers and Parkinsons screening will add the age 35 & over markets.
More information

Advisors

Tim Vatuone
Admin
Tim Vatuone

Employees

Glenn Farina
Admin